Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma. Early clinical studies of carboplatin were performed in 1982. Carboplatin was developed as an analog of cisplatin with reduced nephrotoxicity and vomiting.
Carboplatin was granted FDA approval on 3 March 1989.
Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
Institute of Child Health at University of Bristol, Bristol, England, United Kingdom
Royal London Hospital, London, England, United Kingdom
Sir James Spence Institute of Child Health, Newcastle-Upon-Tyne, England, United Kingdom
Our Lady's Hospital for Sick Children, Dublin, Ireland
Great Ormond Street Hospital for Children NHS Trust, London, England, United Kingdom
Birmingham Children's Hospital, Birmingham, England, United Kingdom
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
University of New Mexico, Albuquerque, New Mexico, United States
Addenbrooke's Hospital, Cambridge, England, United Kingdom
Birmingham Children's Hospital, Birmingham, England, United Kingdom
Leicester Royal Infirmary, Leicester, England, United Kingdom
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Mason District Hospital, Havana, Illinois, United States
Greater Baltimore Medical Center Cancer Center, Baltimore, Maryland, United States
Lyndon Baines Johnson General Hospital, Houston, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
University of Maryland, Baltimore, Maryland, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Santiago De Compostela, Spain
Rush-Copley Cancer Care Center, Aurora, Illinois, United States
Graham Hospital, Canton, Illinois, United States
Mason District Hospital, Havana, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.